Christopher N Silk

Title: Christopher N Silk: Innovator in Bladder Cancer Surveillance

Introduction

Christopher N Silk is a notable inventor based in Redwood City, California. He has made significant contributions to the field of cancer surveillance, particularly focusing on bladder cancer. His innovative methods aim to improve patient monitoring and outcomes.

Latest Patents

Christopher holds a patent for "DNA methylation and mutational analysis methods for bladder cancer surveillance." This patent outlines methods for monitoring bladder cancer patients and analyzing patient samples for the presence of methylated DNA and specific gene mutations. The analysis results can be correlated with clinical outcome measures, such as the risk of bladder cancer recurrence.

Career Highlights

Christopher is currently employed at Genomic Health, Inc., where he applies his expertise in genomic analysis to enhance cancer surveillance techniques. His work is pivotal in developing methods that can lead to better patient management and treatment strategies.

Collaborations

He collaborates with esteemed colleagues, including Margarita Lopatin and Athanasios Tsiatis, to advance research and innovation in the field of cancer detection and monitoring.

Conclusion

Christopher N Silk's contributions to bladder cancer surveillance through his patented methods exemplify the importance of innovation in healthcare. His work continues to impact patient outcomes positively.